XNCR
XNCR
NASDAQ · Biotechnology

Xencor Inc

$35.03
+4.39 (+14.33%)
Financial Highlights (FY 2026)
Revenue
128.04M
Net Income
-93,724,957
Gross Margin
—
Profit Margin
-73.2%
Rev Growth
-8.6%
D/E Ratio
0.19
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 60.6% 60.6%
Operating Margin -148.6% -133.8% -5.1% -5.6%
Profit Margin -73.2% -69.5% -6.3% -5.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 128.04M 140.13M 205.11M 207.84M
Gross Profit — — 124.21M 125.86M
Operating Income -190,327,422 -187,473,656 -10,389,491 -11,650,007
Net Income -93,724,957 -92,319,646 -12,900,416 -11,029,247
Gross Margin — — 60.6% 60.6%
Operating Margin -148.6% -133.8% -5.1% -5.6%
Profit Margin -73.2% -69.5% -6.3% -5.3%
Rev Growth -8.6% -8.6% +24.6% -9.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 175.26M 175.26M 77.39M 67.20M
Total Equity 930.26M 930.26M 595.63M 536.70M
D/E Ratio 0.19 0.19 0.13 0.13
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -179,615,532 -186,751,401 -15,864,221 -15,646,651
Free Cash Flow — — -6,278,593 -9,889,518